What the institutional money is doing on MRNA right now — dark pool, options positioning, and where the news and the money disagree. Free.
News is neutral on the deal itself, but money shows defensive hedging (puts outweigh calls 2-to-1) and no squeeze pressure, suggesting institutions are protecting downside rather than betting on upside.
News is bullish on the stock's performance and pipeline, but money shows put-heavy positioning (2.9x more puts than calls in flow) and balanced institutional activity, signaling skepticism about further gains.
News highlights Moderna's strong run and hints at more upside, but options show defensive put accumulation and no squeeze setup, suggesting institutions are taking profits or hedging against pullback.
This is a product comparison with no directional signal; money data shows no change in MRNA positioning, so no divergence to report.
News is neutral on the deal; MRNA money shows no change—defensive puts and balanced institutional flow persist, unaffected by competitor moves.
A divergence is when the news narrative and the institutional money flow point in opposite directions — a bearish headline while large call premium is bought, or heavy dark-pool selling under a bullish story. It signals the crowd and the desks may disagree.
Dark-pool volume — The share of trading done off-exchange, where institutions move size quietly. Well above ~40% means big players are active.
Max pain — The price where the most options expire worthless — positioning often gravitates toward it near expiry.
Call wall / Put floor — Strikes with the heaviest call/put open interest — they often act as short-term resistance and support.
Put/Call ratio — Below ~0.7 leans bullish (more calls); above ~1 leans defensive (more puts).
